Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsSunpharmaceuticalindustries

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Hold Glenmark Pharma, says Rajat Bose

      Rajat Bose of rajatkbose.com is of the view that one may hold Glenmark Pharma.

    • Buy Hindustan Unilever, Mindtree, Sun Pharma; sell Jaiprakash Associates: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Hindustan Unilever, Mindtree and Sun Pharma and sell Jaiprakash Associates.

    • Here are a few stock ideas from SP Tulsian

      In an interview to CNBC-TV18, SP Tulsian of sptulsian.com shared his readings and outlook on specific stocks and sectors.

    • Buy Mahindra & Mahindra, Sun Pharmaceutical Industries, Piramal Enterprises: Rahul Shah

      Rahul Shah of Motilal Oswal recommends buying Mahindra & Mahindra, Sun Pharmaceutical Industries and Piramal Enterprises.

    • Buy Indo Count Industries, Dr Reddy's Laboratories, Motherson Sumi: Chandan Taparia

      Chandan Taparia of Motilal Oswal Securities is of the view that one may buy Indo Count Industries, Dr Reddy's Laboratories and Motherson Sumi.

    • Hold Sun Pharma, says Rajat Bose

      Rajat Bose of rajatkbose.com is of the view that one my hold Sun Pharma.

    • Prefer Natco Pharma, says Gaurang Shah

      Gaurang Shah of Geojit Financial Services is of the view that one may prefer Natco Pharma.

    • Goldman Sachs retains Buy on Sun Pharma after USFDA accepts NDA filing for OTX-101

      The research house said delayed Halol resolution & US price erosion intensity are key risks to its rating.

    • Vedanta may test Rs 336, Sun Pharma Rs 600: Hemant Thukral

      Hemant Thukral of Aditya Birla Money feels that Vedanta may test Rs 336.

    • Buy, Sell, Hold: 4 stocks and 1 event are on analysts’ radar today

      Marico, NTPC, and Sun Pharma, among others, are being tracked by investors on Thursday.

    • Look at Sun Pharma, says Prakash Diwan

      Prakash Diwan of Altamount Capital Management is of the view that one may look at Sun Pharma.

    • Exit Wockhardt, prefer Sun Pharma: Shahina Mukadam

      Shahina Mukadam, Independent Market Expert is of the view that one mat exit Wockhardt and prefer Sun Pharma.

    • Buy Tech Mahindra, Apollo Hospitals Enterprises: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com advises buying Edelweiss Financial Services, Tech Mahindra and Apollo Hospitals Enterprises.

    • Buy SBI, Axis Bank, Sun Pharma: Yogesh Mehta

      Yogesh Mehta, Associate VP at MOSL is of the view that one may buy SBI, Axis Bank and Sun Pharma.

    • Top buy, sell ideas by Mitessh Thakkar, Sandeep Wagle & Ashwani Gujral for December 27

      Ashwani Gujral of ashwanigujral.com is of the view that one may buy PC Jeweller with a target at Rs 458.

    • Buy Infibeam Incorporation, Sun Pharma: Mitessh Thakkar

      Mitessh Thakkar of mitesshthakkar.com advises buying Infibeam Incorporation and Sun Pharma.

    • Buy JSW Steel, Sun Pharma, Shriram Transport Finance: Rahul Shah

      Rahul Shah, Associate VP at Motilal Oswal advises buying JSW Steel, Sun Pharma and Shriram Transport Finance.

    • Top buy & sell ideas by Mitessh Thakkar & Prakash Gaba for December 21

      Prakash Gaba of prakashgaba.com recommends buying DLF with target at Rs 260 and stop loss at Rs 237, a buy on Larsen & Toubro with a target at Rs 1256 and stop loss at Rs 1222 and a buy also on NIIT Tech with target at Rs 660 and stop loss at Rs 662.

    • Buy IndusInd Bank, JSW Steel, Sun Pharmaceutical Industries: Rahul Shah

      Rahul Shah of Motilal Oswal recommends buying IndusInd Bank, JSW Steel and Sun Pharmaceutical Industries.

    • Buy Granules India, Sun Pharmaceutical Industries: Prakash Gaba

      Prakash Gaba of prakashgaba.com is of the view that one can buy Granules India and Sun Pharmaceutical Industries.

    • Sun Pharma down 1% as CLSA maintains sell call

      Global research firm sees increased competition for its psoriasis drug

    • Buy, Sell, Hold: 10 stocks and 1 event are being tracked by analysts today

      Tata Global, BHEL, and IRB Infra, among others, are on the radar of investors on Thursday.

    • Top buy & sell ideas by Ashwani Gujral, Mitessh Thakkar & Prakash Gaba for December 7

      Mitessh Thakkar of miteshthacker.com is of the view that one can sell Godfrey Phillips with a stop loss of Rs 990 for target of Rs 930 and buy Godrej Consumer with a stop loss of Rs 980 for target of Rs 1050.

    • Buy, Sell, Hold: 5 stocks and 1 sector are on analysts’ radar today

      Voltas, Alkem Labs, among others, are being tracked by investors on Thursday.

    • Exit Granules India on rallies: Shahina Mukadam

      Shahina Mukadam, Independent Market Expert is of the view that one may exit Granules India on rallies.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347